Covishield 3rd dose increases antibody response against Omicron: Study Roshni Dhar14 Jan 2022 5:38 PM ISTA third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant,...
Health Bulletin 14/January/2022 Roshni Dhar14 Jan 2022 5:07 PM ISTHere are Top Health stories of the dayIndia's daily positivity rate at 14.78%, over 12.72 lakh active casesGujarat to provide 10 % reservation to...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
AstraZeneca closes Eplontersen agreement with Ionis Medical Dialogues Bureau2 Jan 2022 10:00 AM ISTUK: AstraZeneca has announced that the company has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. for...
Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months Ruchika Sharma25 Dec 2021 3:40 PM ISTNew Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...
Covishield protection diminishes after 3 months: Lancet study Ruchika Sharma24 Dec 2021 9:30 AM ISTLondon: The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive,...
Booster dose of AstraZeneca COVID vaccine effective against Omicron Ruchika Sharma23 Dec 2021 3:52 PM ISTUK: Citing the Oxford University lab study , drug major AstraZeneca has announced that the booster dose of the company's COVID vaccine Vaxzevria...
AstraZeneca, Make-A-Wish foundation join hands to aid children suffering from critical ailments Ruchika Sharma21 Dec 2021 10:00 AM ISTMumbai: AstraZeneca India Private Limited has joined hands with 'Make-A-Wish' Foundation India to fulfil the wishes of about 500 children...
AstraZeneca gets CDSCO panel nod to study lupus erythematosus drug Anifroluma Medical Dialogues Team19 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the...
AstraZeneca antibody cocktail Evusheld works against Omicron: USFDA study Ruchika Sharma18 Dec 2021 4:44 PM ISTNew Delhi: AstraZeneca has announced that Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of...
AstraZeneca in touch with Indian authorities for COVID drug Evusheld Ruchika Sharma10 Dec 2021 2:34 PM ISTEvusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US for COVID-19 pre-exposure...
AstraZeneca COVID antibody cocktail authorized by USFDA Ruchika Sharma9 Dec 2021 1:24 PM ISTUK: AstraZeneca has recently announced that Evusheld (tixagevimab co-packaged with cilgavimab), a Long-Acting Antibody (LAAB) combination, has...
